Vertex cystic fibrosis combination succeeds in late-stage trials

Vertex Pharmaceuticals said on Tuesday its Kalydeco cystic fibrosis treatment givenwith an experimental drug demonstrated significant improvements in lung function in a pair of late-stage trials the company plans to use to seek approval for the combination therapy....